5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman

4. VYNE Therapeutics Inc. (NASDAQ: VYNE)

Edelman’s Stake Value: $46,368,000
Percentage of Joseph Edelman’s 13F Portfolio: 0.58%
Number of Hedge Fund Holders: 9

VYNE Therapeutics Inc. (NASDAQ: VYNE) is a pharmaceutical company, which focuses on developing and commercializing various medicines for dermatology. The company was founded in 2003 and is placed fourth on the list of 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman. VYNE currently has a $184.48 million market capitalization. 

On May 6, VYNE Therapeutics Inc. (NASDAQ: VYNE) declared its earnings per share of -$0.37, beating market predictions by $0.03. On March 1, VYNE Therapeutics shares gained 5% after announcing its development plans for FMX114 for the treatment of atopic dermatitis. 

The stock is a new arrival on Joseph Edelman’s portfolio, as his hedge fund bought about 6.77 million shares of the company, worth $46.37 million. In the first quarter of 2021, 9 hedge funds in Insider Monkey’s database held stakes in VYNE Therapeutics Inc. (NASDAQ: VYNE), compared to 11 funds in the fourth quarter of 2020.